Johnson & Johnson says it will delay European COVID-19 vaccine rollout

Johnson & Johnson says it will delay the rollout of its COVID-19 vaccine in Europe after US authorities moved to suspend the use of the shot due to health concerns.

The US Food and Drug Administration and the Centers for Disease Control moved to “pause” the one-shot COVID-19 inoculation over six reported cases of a rare type of blood clot in the United States.

“We have made the decision to proactively delay the rollout of our vaccine in Europe,” J&J says, adding that it is reviewing the cases with European health authorities.

Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed